Webinar: CSL Research Acceleration Initiative Funding Opportunity
February 6, 2023
CSL Research Acceleration Initiative Funding Opportunity
CSL Behring – CSL Research Acceleration Initiative ($400,000 award, brief abstract deadline February 23, 2023). CSL is a leading global biotech company that develops and delivers innovative biotherapies to help people living with life-threatening medical conditions live full lives. CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organizations. These partnerships provide funding and access to industry experts for scientists working on novel biotherapeutic strategies in CSL’s therapeutic areas. Successful applicants will receive up to $400k over 2 years. Researchers who wish to apply are required to submit a non-confidential, 300 word online abstract by February 23, 2023. Interested researchers are invited to join an online information session to learn more.
CSL Research Acceleration Initiative
- $400,000 award
- Brief Abstract Deadline: February 23, 2023
Monday, February 6 • 4pm ET
Click here to learn more about CSL’s priority areas of interest.